Presentation TCT 2013 TCT-81. Doppler-flow and pressure derived hyperemic microvascular resistance measurements predict abnormal H[sub]2[/sub][sup]15[/sup]O PET-quantified myocardial blood flow after... Presenter: Guus Waard October 29, 2013
Presentation TCT 2013 Sodium bicarbonate versus normal saline hydration for mortality: a meta-analysis of randomized controlled trials Presenter: Daniel M. Pearlman October 29, 2013
Presentation TCT 2013 Largest Single-Center Experience of Percutaneous Left Ventricular Transapical Access for Structural Heart Disease Interventions Presenter: Chad Kliger October 29, 2013
Presentation TCT 2013 Why I Believe PCI Is (Usually) Better for My Patients Presenter: Paul Teirstein October 29, 2013
Presentation TCT 2013 Benefits of Revascularization in Improving Quality of Life in SIHD: Metrics, Magnitude and Patient Selection Presenter: John Spertus October 29, 2013
Presentation TCT 2013 How Important Is Paravalvular Leak After TAVR and Will This Limit Its Penetration? Presenter: Samir Kapadia October 29, 2013
Presentation TCT 2013 How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis? Presenter: Soo-Jin Kang October 29, 2013
Presentation TCT 2013 TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV... Presenter: Thierry Lefevre October 29, 2013
Presentation TCT 2013 Synthesis of the Current US and EU Guidelines for Management of SIHD (Similarities and Differences) Presenter: Kevin Beatt October 29, 2013